Journals / Türk Kardiyoloji Derneği Arşivi / 2011 / Cilt: 39 - Sayı: 3

Procedural success and short- and mid-term results of percutaneous closure of persistent arterial duct with the Amplatzer Duct Occluder II

Duktus arteriyozus açıklığının Amplatzer Duct Occluder II ile perkütan kapatılmasında işlem başarısı ve kısa-orta dönem takip sonuçları

Pages
219–223
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: In all the cases, the ADO II device was found effective and reliable for closure of PADs of less than 6 mm.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: We evaluated the effectiveness and reliability of percutaneous closure of persistent arterial duct (PAD) with the Amplatzer Duct Occluder II (ADO II), together with short- and mid-term results.
📊
Key Findings & Data:Study design: The study included 16 patients (10 girls, 6 boys; median age 6 years; range 5 months to 12 years) who underwent percutaneous PAD closure with the ADO II device.
💡
Conclusion & Impact:Conclusion: In all the cases, the ADO II device was found effective and reliable for closure of PADs of less than 6 mm.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: We evaluated the effectiveness and reliability of percutaneous closure of persistent arterial duct (PAD) with the Amplatzer Duct Occluder II (ADO II), together with short- and mid-term results. Study design: The study included 16 patients (10 girls, 6 boys; median age 6 years; range 5 months to 12 years) who underwent percutaneous PAD closure with the ADO II device. The ductus diameter was less than 6 mm in all the cases. According to the Krichenko classification, 10 patients had type A, five patients had type E, and one patient had residual PAD. The patients were assessed by aortography and echocardiography. The mean follow-up was 13.9 months (range 2 to 23 months). Results: Closure of PAD was successfully performed via the arterial approach in all the patients. The median ductus waist diameter was 3 mm (range 2 to 5 mm), the median device waist diameter was 4 mm (range 3 to 6 mm), and the waist length was 4 or 6 mm. The mean fluoroscopy time and the mean procedure time were 10.6 min (range 4 to 39 min) and 30 min (range 18 to 80 min), respectively. Immediate aortography following the procedure showed shunt only through the device lumen. No residual shunt or increases in aortic and left pulmonary flow velocities were observed in echocardiographic examinations. No complications occurred during the procedure and follow-up. Conclusion: In all the cases, the ADO II device was found effective and reliable for closure of PADs of less than 6 mm.

Özet

Amaç: Bu çalışmada duktus arteriyozus açıklığının (DAA) transkateter yöntemle tedavisinde Amplatzer Duct Occluder II’nin (ADO II) etkinliği, güvenirliği ve kısa-orta dönem takip sonuçları değerlendirildi. Çalışma planı: Çalışmada DAA tanısıyla ADO II ile perkütan kapatma uygulanan 16 hasta (10 kız, 6 erkek; ortanca yaş 6; dağılım 5 ay-12 yıl) değerlendirildi. Tüm olgularda DAA çapı 6 mm’nin altında idi. Krichenko sınıflandırmasına göre, 10 hastada tip A, beş hastada tip E, bir hastada da cerrahi sonrası rezidüel DAA vardı. İşlem sonrasında hastalar aortografi ve ekokardiyografi ile değerlendirildi. Ortalama takip süresi 13.9 ay (dağılım 2-23 ay) idi. Bulgular: Kapatma işlemi tüm hastalarda arteryel yaklaşımla başarıyla gerçekleştirildi. Kanalın en dar olduğu yerin ortancası 3 mm (dağılım 2-5 mm), cihaz bel çapının ortancası 4 mm (dağılım 3-6 mm), cihaz bel uzunluğu 4 veya 6 mm idi. Floroskopi süresi ortalama 10.6 dk (dağılım 4-39 dk), işlem süresi ortalama 30 dk (dağılım 18-80 dk) bulundu. İşlemden hemen sonra yapılan aortografide sadece cihaz içinden geçiş izlendi. İşlem sonrası ve takipler sırasında yapılan ekokardiyografik incelemelerde ise hiçbir hastada kaçak, aort ve sol pulmoner arter akımlarında anlamlı hızlanma izlenmedi. Hiçbir hastada komplikasyonla görülmedi. Sonuç: Tüm olgularda ADO II cihazının 6 mm’den küçük DAA’ların kapatılmasında etkin ve güvenilir olduğu görüldü.

🔖

Cite This Article

BAYKAN, A., AŞKER, M., NARİN, N., KAYANÇİÇEK, H., KARAPINAR, H., YILMAZ, A., GÜL, İ., KÜÇÜKDURMAZ, Z., GÜMRÜKÇÜOĞLU, H. A., SEZER, S., KAYA, M. G. (2022). Procedural success and short- and mid-term results of percutaneous closure of persistent arterial duct with the Amplatzer Duct Occluder II. Türk Kardiyoloji Derneği Arşivi, Cilt: 39 - Sayı: 3, 219–223. https://ajindex.com/articles/633120

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (13)

  1. Gross RE, Hubbard JP. Landmark article Feb 25, 1939: Surgical ligation of a patent ductus arteriosus. Report of first successful case. By Robert E. Gross and John P. Hubbard. JAMA 1984;251:1201-2
  2. Porstmann W, Hieronymi K, Wierny L, Warnke H. Nonsurgical closure of oversized patent ductus arteriosus with pulmonary hypertension. Report of a case. Circulation 1974;50:376-81
  3. Masura J, Walsh KP, Thanopoulous B, Chan C, Bass J, Goussous Y, et al. Catheter closure of moderate- to large-sized patent ductus arteriosus using the new Amplatzer duct occluder: immediate and short-term results. J Am Coll Cardiol 1998;31:878-82
  4. Bilkis AA, Alwi M, Hasri S, Haifa AL, Geetha K, Rehman MA, et al. The Amplatzer duct occluder: experience in 209 patients. J Am Coll Cardiol 2001;37:258-61
  5. Ing FF, Sommer RJ. The snare-assisted technique for transcatheter coil occlusion of moderate to large patent ductus arteriosus: immediate and intermediate results. J Am Coll Cardiol 1999;33:1710-8
  6. Krichenko A, Benson LN, Burrows P, Möes CA, McLaughlin P, Freedom RM. Angiographic classification of the isolated, persistently patent ductus arteriosus and implications for percutaneous catheter occlusion. Am J Cardiol 1989;63:877-80
  7. The Amplatzer Duct Occluder II. Product specifications. AGA Medical Corporation, Golden Valley, MN, USA, 2008
  8. Huggon IC, Qureshi SA. Is the prevention of infective endarteritis a valid reason for closure of the patent arterial duct? Eur Heart J 1997;18:364-6
  9. Bonhoeffer P, Borghi A, Onorato E, Carminati M. Transfemoral closure of patent ductus arteriosus in adult patients. Int J Cardiol 1993;39:181-6
  10. Thanopoulos BV, Eleftherakis N, Tzannos K, Stefanadis C, Giannopoulos A. Further experience with catheter closure of patent ductus arteriosus using the new Amplatzer duct occluder in children. Am J Cardiol 2010;105:1005-9
  11. Saliba Z, El-Rassi I, Abi-Warde MT, Chehab G, Daou L, Khater D, et al. The Amplatzer Duct Occluder II: a new device for percutaneous ductus arteriosus closure. J Interv Cardiol 2009;22:496-502
  12. Dua J, Chessa M, Piazza L, Negura D, Micheletti A, Bussadori C, et al. Initial experience with the new Amplatzer Duct Occluder II. J Invasive Cardiol 2009; 21:401-5
  13. Forsey J, Kenny D, Morgan G, Hayes A, Turner M, Tometzki A, et al. Early clinical experience with the new Amplatzer Ductal Occluder II for closure of the persistent arterial duct. Catheter Cardiovasc Interv 2009;74:615-23.